| Literature DB >> 33528113 |
Jingyan Liu1, Zhihui Li1, Keyu Yan1, Gehang Ju1, Wen Qiu1.
Abstract
Dapoxetine is the first oral medication specifically developed for the on-demand treatment of premature ejaculation. The pharmacokinetics and safety of 30 mg (n = 40) and 60 mg (n = 38) dapoxetine in healthy Chinese under fasted and fed states were assessed in 2 studies. Both studies are random, single-center, 2-period, open-label, 2-way crossover designs. Plasma concentration of dapoxetine was determined by high-performance liquid chromatography-tandem mass spectrometry, and the pharmacokinetic parameters were calculated using noncompartmental analysis. Dapoxetine was quickly absorbed and reached maximum concentration 1 to 3 hours after oral administration. Elimination was biphasic, and the plasma concentration decreased to 3% to 7% of maximum concentration by 24 hours while half-life was 15 to 18 hours. Meantime, high-fat meals slightly increased its exposure. Both doses of dapoxetine were well tolerated. The adverse events in the high-dose group under fasted and fed states were 37.9% and 19.0%, respectively.Entities:
Keywords: dapoxetine; dose proportion; food effect; pharmacokinetics; premature ejaculation; safety
Mesh:
Substances:
Year: 2021 PMID: 33528113 DOI: 10.1002/cpdd.919
Source DB: PubMed Journal: Clin Pharmacol Drug Dev ISSN: 2160-763X